has been shown to depend mainly on the extracellular domain of the ␤ 3 chain. 6 Although most studies have indicated that ligand-induced receptor activation is a necessary prerequisite for the association of the growth factor receptors with integrins such as ␣ v ␤ 3 , 7,8 other reports have revealed that, under conditions of elevated expression levels of both components, the interaction between growth factor receptors and integrins may occur even in the absence of soluble growth factor. 6, 9 For instance, ligand-independent PDGFR-␤ phosphorylation was observed in fibroblasts attached to ␤ 1 integrin substrates, 10 suggesting that ECM-induced integrinmediated activation of growth factor receptors may bypass the requirement of growth factors for inducing a proliferative or migratory cellular response.
Common Intracellular Signaling Pathways
Because the colocalization of growth factor receptors and integrins often occurs in focal contacts where the integrins cluster on binding to their ECM ligands, molecular exchanges between their respective signaling pathways may be facilitated. Additionally, and as a further indication of the potentially coordinated mechanisms regulating cellular activation, many of the signaling pathways induced by growth factor receptors are also engaged after ECM-induced activation of integrins. For instance, several kinases such as FAK, c-Src, Jnk, PKC, and MAP kinases are stimulated by ␣ v ␤ 3 integrin clustering. 11 Similarly, on binding of VEGF-A to its main endothelial signaling receptor VEGFR-2, the receptor autophosphorylates, leading to the activation of multiple signaling cascades via the recruitment of various initiator components, eg, adaptor molecules such as Grb2 and the Src family of tyrosine kinases (c-Src, Fyn, Yes); Ras and Rho GTPases; as well as tyrosine phosphatases (SHP-1, SHP-2). 12, 13 Further downstream effector molecules include fokal adhesion kinase (FAK), PI3K, Jnk, and MAP kinases, which contribute to the launching of cellular programs regulating cell morphology and chemotaxis as well as increased survival or proliferation, all concordant with an angiogenic cellular phenotype.
ECM Influences on Growth Factor-Induced Cellular Responses
Among the integrins, ␣ v ␤ 3 integrins seem to occupy a particular function in angiogenesis. Whereas in vitro experiments have shown that ␣ v ␤ 3 integrins are upregulated by VEGF-A in microvascular endothelial cells, 14 in vivo studies have frequently revealed elevated levels of ␣ v ␤ 3 integrins at sites of active angiogenesis. 15 In addition, blocking antibodies or small molecule inhibitors (RGD cyclic peptide) against ␣ v ␤ 3 display potent antiangiogenic effects. 15 Indeed, a neutralizing antibody against ␣ v ␤ 3 , Vitaxin, has been tested in clinical trials against metastatic melanoma or prostate cancer based on its antiangiogenic properties. 16 Interestingly, the binding of ␣ v ␤ 3 integrin to the ECM has been shown to potentiate the proliferative and migratory cellular response to various growth factors such as insulin, EGF, PDGFs, and VEGF-A. 7, 8, [17] [18] [19] For instance, cellular attachment to vitronectin or fibrinogen, both specific ligands for ␣ v ␤ 3 integrins, increases basal HUVEC proliferation by 2.5-fold and VEGF-A-stimulated proliferation by 4.7-fold, as compared with cells attached to BSA. 8 At the same time, other types of ECM, such as the ␣ 5 ␤ 1 ligand fibronectin and the ␣ 2 ␤ 1 ligand collagen-1, were significantly less effective in stimulating VEGF-induced endothelial responses in these cells. Further support for the specific regulatory function of the VEGFR-2/␣ v ␤ 3 integrin complex is given by the demonstration that blocking ␤ 3 integrin antibodies, but not anti-␤ 1 antibodies, inhibit VEGF-A-induced VEGFR-2 phosphorylation, and leads to drastically reduced cellular migration and proliferation. 8 Thus, ␣ v ␤ 3 integrins seem to play a special role in coordinating the activity of several growth factor receptor systems with links to angiogenesis.
In this issue of Circulation Research, Mahabeleshwar et al 20 expand on the specific features of the interactions occurring between integrins and the VEGFR-2 growth factor receptor in primary human endothelial cells (HUVECs). Similar to previous studies, 8 they show that cellular adhesion to the ␣ v ␤ 3 integrin ligand vitronectin, rather than to the ␣ 2 ␤ 1 ligand collagen or the ␣ 6 ␤ 1 /␣ 6 ␤ 4 ligand laminin, dramatically enhances VEGF-A-induced VEGFR-2 phosphorylation, and leads to a complex formation between VEGFR-2 and ␣ v ␤ 3 integrin molecules. Further, this ECM-derived potentiation of VEGF signaling is significantly reduced by blocking antibodies against either ␣ v or ␤ 3 integrin chains, indicating the specific involvement of ␣ v ␤ 3 integrins. Conversely, Mahabeleshwar et al 20 also demonstrate that VEGF-A stimulation increases vitronectin-induced ␤ 3 integrin phosphorylation. Importantly, they reveal an essential role of c-Src in mediating both growth factor-induced as well as ECM-stimulated phosphorylation of the ␤ 3 integrin. Further, c-Src is found to associate with both VEGFR-2 and ␤ 3 integrin, and c-Srcmediated ␤ 3 phosphorylation is shown to be required for the formation of the VEGFR-2/␣ v ␤ 3 integrin complex.
On a molecular level, the authors convincingly demonstrate direct phosphorylation by recombinant purified c-Src of the tyrosine residues Y747 and Y759 in the ␤ 3 integrin cytoplasmic tail. 20 Furthermore, they show that these same residues are targeted during VEGF-A-induced ␤ 3 integrin phosphorylation. Although the potential role of FAK, previously shown to form a dual kinase signaling complex with c-Src, 21 was not investigated in this current study, previous work has suggested that VEGF-A-induced c-Src phosphorylation specifically mediates the association between FAK and ␣ v ␤ 5 rather than with ␣ v ␤ 3 integrin. 22 Of note, the presence of both c-Src and ␤ 5 , but not ␤ 3 integrin, was found to be critical for the VEGF-A-induced vascular permeability effects in mice. 22, 23 On a functional level, the studies performed by Mahabeleshwar et al 20 reveal that inactivation of c-Src is associated with significantly decreased endothelial adhesion to vitronectin, but not to collagen or laminin, indicative of the importance of c-Src in ␣ v ␤ 3 -dependent cellular adhesion. Moreover, the c-Src-mediated structural modification of ␤ 3 results in activation of ␣ v ␤ 3 integrins, leading to augmented soluble ligand (fibrinogen) binding capacity, as well as to enhanced chemotaxis and precapillary tube formation of endothelial cells in response to VEGF-A stimulation. Additionally, cellular adhesion to vitronectin, leading to ␣ v ␤ 3 integrin activation, was found to be associated with increased basal as well as VEGF-A-stimulated endothelial proliferation as compared with cells grown on collagen or laminin. This observation could be partially explained by a synergistic stimulation of the Akt pathway occurring in cells attached to vitronectin and stimulated by VEGF-A. 20 However, whether c-Src is equally essential for VEGF-A-induced integrin-mediated endothelial responses in vivo remains to be further investigated.
Taken together, these results emphasize importance of ECM in influencing, via integrin outside-in signals, growth factor-induced signaling pathways of crucial importance to angiogenesis, such as endothelial migration, tube formation, and proliferation. Vice versa, the study by Mahabeleshwar et al 20 reveals the direct effects of activated growth factor receptors on integrin functional status that is closely linked to cell motility. Indeed, the relationship between VEGFR-2 and ␤ 3 integrin in endothelial cells seems to be reciprocally stimulatory. The molecular interactions, mainly regulated by c-Src, largely influences the endothelial responsiveness to VEGF-A as well as to integrin ligation of the ECM, and may thus be of crucial importance for the regulation of angiogenesis and of relevance for strategies aiming at therapeutic stimulation of neovascularization in ischemic organs. An indication of other potential ways that ␣ v ␤ 3 integrins may influence growth factor-mediated signals is the observation that integrins are necessary for the second wave of MAP kinase activation after soluble growth factor (FGF-2) stimulation. 24 Additionally, ␣ v ␤ 3 integrins may regulate the cell cycle by suppressing gene expression of molecules such as p53 and p21 WAF/CIP1 , and by increasing Bax:Bcl-2 ratios, resulting in cellular protection against apoptosis. 25 In support, activated ␣ v ␤ 3 integrins constitute an important survival signal for nascent blood vessels, and conversely ␣ v ␤ 3 integrin inhibitors have been found to induce apoptosis in endothelial cells. 2 Some key questions still remain with regard to the potential differences between the role of ␣ v ␤ 3 integrins in regulation of physiological versus pathological angiogenesis, particularly as data generated from different transgenic mouse models have lead to some discordant findings. Whereas it was found that the majority of ␣ v integrin knock-out mice die before birth because of vascular defects, 26 the ␤ 3 knock-out mice appear grossly normal, with the exception of a recently published phenotype of reduced coronary capillary vessel maturity in adult male mice, 27 suggestive of a specific role for ␣ v ␤ 3 integrins in postnatal cardiac remodeling. In addition, these mice display an increased pathological angiogenic phenotype, 28 with enhanced sensitivity to VEGF-A-stimu-
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Integrin and VEGFR-2 Interactions lated angiogenesis as well as rapid tumor growth. This shows that, although ␣ v ␤ 3 integrin antagonists have clearly antiangiogenic effects, 15 the ␤ 3 integrin is not necessary for physiological or pathological angiogenesis. One possible explanation for this unexpected finding is that VEGFR-2 levels may be elevated in blood vessels by way of overcompensation in the absence of ␤ 3 integrin expression. 29 Similarly, whereas VEGF-A induces ␣ v ␤ 3 integrin expression in vitro in microvascular endothelial cells, 13 the activation of ␣ v ␤ 3 integrin has been found to reduce VEGFR-2 expression levels in endothelial cells. 28, 29 This feed-back loop may constitute a protection against unrestrained angiogenic stimulation, ensuring that the blood vessel response remains finely tuned to the specific requirements of the tissue.
In contrast, a more recently generated mouse knock-in model, expressing a ␤ 3 negative mutant that cannot be phosphorylated, displayed as expected an impaired pathological angiogenic phenotype with features of reduced VEGF-A sensitivity. 30 Conversely, mice overexpressing constitutively active ␤ 3 integrin were also reported to exhibit impaired pathological angiogenic responses characterized by reduced tumor vessel density with more immature and small vessels, leading to reduced tumor growth. 29 In the wake of these different studies, the ␣ v ␤ 3 integrin have been proposed by some to play an antiangiogenic role, 1,31 rather than a priming or facilitating function for angiogenic growth factor-mediated signaling. Thus, the study by Mahabeleshwar et al 20 adds valuable further mechanistic insight to the issue and ensures that the debate regarding the role of integrins in angiogenesis will go on more informed.
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